Skip to main content
2026 ACCP Annual Meeting Main banner
Final Program


Full Schedule

Full Schedule

  • Friday, September 25, 2026
  • 6:00 PM - 10:00 PM EDT
    ACCP Executive Committee Meeting & Dinner (Invitation only)
  • Saturday, September 26, 2026
  • 7:00 AM - 7:00 PM EDT
    ACCP Registration Open
  • 8:00 AM - 3:00 PM EDT
    ACCP Board of Regents Meeting (Invitation only)
  • 8:00 AM - 5:00 PM EDT
    Clinical Pharmacology Curriculum Review Course
    Co-Chair & Faculty: Craig W. Hendrix, MD (he/him/his) – Johns Hopkins Univ
    Co-Chair & Faculty: Lionel Lewis, MD (he/him/his) – The Geisel School of Medicine at Dartmouth
    Evidence-based Medicine/Therapeutic Drug Monitoring/Real World Evidence
  • 8:00 AM - 5:00 PM EDT
    Pre-meeting Workshop: Cardiac Safety in Drug Development: Navigating Risk from Preclinical to Labeling
    Chair & Faculty: Hee Jae Choi, PharmD – Boehringer Ingelheim
    Faculty: Borje Darpo, MD, PhD (he/him/his) – Clario Holdings Inc & Independent
    Faculty: Joanna Parkinson, PhD – AstraZeneca plc
    Faculty: Ravi Shankar Singh, PhD, FCP – Pfizer Inc
    Faculty: Elijah J. Weber, PhD (he/him/his) – AstraZeneca plc
    Clinical Trial Design & Statistical Approaches
     CE: 6.0
  • 7:00 PM - 10:00 PM EDT
    PharmaFete
  • Sunday, September 27, 2026
  • 6:30 AM - 5:00 PM EDT
    ACCP Registration Open
  • 7:00 AM - 7:45 AM EDT
    Continental Breakfast
  • 7:00 AM - 7:45 AM EDT
    New Member & First-time Attendee Welcome
  • 7:00 AM - 7:45 AM EDT
    Student, Trainee & Early-stage Professional (STEP & ESP) Welcome
  • 7:00 AM - 7:00 PM EDT
    Exhibit Hall Open
  • 7:45 AM - 8:00 AM EDT
    Welcome & Opening Remarks by ACCP President
  • 8:00 AM - 9:30 AM EDT
    Opening Plenary Session
    Co-Chair & Faculty: Lisa von Moltke, MD
    Co-Chair & Faculty: Mary Jimenez, BBA – Alamo Breast Cancer Foundation
    Novel Mechanisms & Emerging Therapeutic Modalities
     CE: 1.5
  • 9:30 AM - 10:00 AM EDT
    Coffee & Networking Break
  • 10:00 AM - 11:30 AM EDT
    Symposium 1: Where Are We Now in Pediatric Cancer Drug Development: 5 Years of the RACE for Children Act
    Faculty: Sarah Leary, MD, MS (she/her/hers) – Seattle Children's & Univ of Washington School of Medicine
    Faculty: Chunze Li, PhD – Genentech Inc
    Specific Populations/Rare Diseases
     CE: 1.5
  • 10:00 AM - 11:30 AM EDT
    Symposium 2: HOT TOPIC: Current & Next Generation of GLP-1 Receptor Agonists & Obesity Drugs: Overcoming Clinical Pharmacology Challenges
    Chair & Faculty: Sabina Paglialunga, PhD – Celerion Inc
    Faculty: Anil Kane, PhD, MBA – Thermo Fisher Scientific Inc
    Faculty: Carolina Säll, PhD – Novo Nordisk A/S
    Faculty: Aernout van Haarst, PhD – Celerion Inc
    Novel Mechanisms & Emerging Therapeutic Modalities
     CE: 1.5
  • 11:30 AM - 1:30 PM EDT
    Lunch Buffet
  • 11:45 AM - 1:15 PM EDT
    Lunch & Awards
  • 1:30 PM - 3:00 PM EDT
    STEP & ESP Panel Discussion & Career Guidance
  • 1:30 PM - 5:00 PM EDT
    Symposium 3: Sustainability in the Research & Development of Medicines: An Opportunity for Clinical Pharmacology
    Co-Chair & Faculty: Qi Liu, PhD – US Food & Drug Administration
    Co-Chair & Faculty: Karthik Venkatakrishnan, PhD – EMD Serono
    Faculty: Kerry Culm, PhD – ModeX Therapeutics Inc
    Faculty: Amelia N N. Deitchman, PharmD, PhD – Univ of California San Francisco
    Faculty: Vaishali Sahasrabudhe, PhD – Pfizer Inc
    Faculty: Piet H. van der Graaf, PharmD, PhD – Certara Inc
    Innovative Clinical Pharmacology Strategies for Dose Optimization/Model-Informed Drug Development
     CE: 3.0
  • 3:00 PM - 3:30 PM EDT
    Coffee & Networking Break
  • 3:00 PM - 5:00 PM EDT
    STEP & ESP Networking Reception
  • 5:00 PM - 7:00 PM EDT
    Opening Reception, Exhibits & Poster Session 1
  • Monday, September 28, 2026
  • 7:00 AM - 7:45 AM EDT
    STEP & ESP Gathering
  • 7:00 AM - 8:00 AM EDT
    Continental Breakfast
  • 7:00 AM - 8:00 AM EDT
    Exhibit Hall Open
  • 7:00 AM - 5:00 PM EDT
    ACCP Registration Open
  • 8:00 AM - 9:30 AM EDT
    Symposium 4: Leveraging Innovative Quantitative Systems Pharmacology, Artificial Intelligence & Machine Learning Approaches for Cytokine Release Syndrome Risk Management in T-Cell Redirecting Therapies
    Co-Chair & Faculty: Junyi Li, PhD (she/her/hers) – Genentech Inc
    Co-Chair & Faculty: Jin Niu, PhD (she/her/hers) – Johnson & Johnson
    Faculty: John Carl Panetta, PhD (he/him/his) – St Jude Children's Research Hosp
    Faculty: Monica Susilo, PhD (she/her/hers) – Genentech Inc
    Innovative Clinical Pharmacology Strategies for Dose Optimization/Model-Informed Drug Development
     CE: 1.5
  • 8:00 AM - 9:30 AM EDT
    Symposium 5: Toward Global Harmonization of Mechanistic Modeling Assessment: Perspectives From the European Medicines Agency & US Food & Drug Administration

    Chair & Faculty: Xinyuan (Susie) Zhang, PhD – Simulations Plus

    Faculty: Pieter Colin, PharmD, PhD – European Medicines Agency

    Faculty: Hao Zhu, PhD – US Food & Drug Administration

  • 8:00 AM - 9:30 AM EDT
    Symposium 5: Toward Global Harmonization of Mechanistic Modeling Assessment: Perspectives From the European Medicines Agency and US Food & Drug Administration
    Chair & Faculty: Xinyuan (Susie) Zhang, PhD (she/her/hers) – Simulations Plus
    Faculty: Sarem Sarem
    Regulatory Science/Legal/Bioethical Considerations
     CE: 1.5
  • 9:30 AM - 10:00 AM EDT
    Coffee & Networking Break
  • 10:00 AM - 11:30 AM EDT
    Invited Keynote: Harnessing Leadership & Collaboration to Drive Change
    Chair & Faculty: Eileen Habelow, PhD
    Novel Mechanisms & Emerging Therapeutic Modalities
  • 11:30 AM - 1:30 PM EDT
    Lunch Buffet
  • 11:45 AM - 1:15 PM EDT
    Lunch & Awards
  • 1:30 PM - 3:00 PM EDT
    Symposium 6: Pharmacogenetics in Specific Populations: Using Novel Experimental Approaches & Modeling & Simulation to Solve Complex Cases

    Co-Chair & Faculty: Catherijne A.J. Knibbe, PhD, PharmD, FCP – Leiden University & St. Antonius Hosp

    Chair & Faculty: Karen Rowland Yeo, PhD – Certara UK Ltd

    Faculty: Steve Leeder, PharmD, PhD – Children’s Mercy Kansas City

    Faculty: Aarti Sawant, PhD – AstraZeneca plc

  • 1:30 PM - 3:00 PM EDT
    Symposium 6: Pharmacogenetics in Specific Populations: Using Novel Experimental Approaches and Modeling & Simulation to Solve Complex Cases
    Co-Chair & Faculty: Catherijne A.J. Knibbe, PhD, PharmD, FCP – Leiden Univ & St Antonius Hosp
    Co-Chair & Faculty: Karen Rowland Yeo, PhD – Certara UK Ltd
    Faculty: Steve Leeder, PharmD, PhD – Children’s Mercy Kansas City
    Faculty: Aarti Sawant, PhD – AstraZeneca plc
    Specific Populations/Rare Diseases
     CE: 1.5
  • 1:30 PM - 5:00 PM EDT
    Symposium 7: HOT TOPIC: Integrating Agentic Artificial Intelligence into Quantitative Clinical Pharmacology: Promise, Practice & Pitfalls
    Chair & Faculty: Ravi Shankar Singh, PhD, FCP – Pfizer Inc
    Faculty: Robert Bies, PhD – Univ at Buffalo
    Faculty: Srijib Goswami, PhD – Insight Rx
    Faculty: Pravin Jadhav, PhD – Vivpro Corp
    Faculty: Emily Nieves, PhD
    Artificial Intelligence/Technology Platforms from Drug Discovery to Patient Care
     CE: 3.0
  • 3:00 PM - 3:30 PM EDT
    Coffee & Networking Break
  • 3:30 PM - 5:00 PM EDT
    Symposium 8: When Rare Meets Young: Harnessing Clinical Pharmacology to Facilitate Dose Selection & Approval for Pediatric Rare Diseases
    Co-Chair & Faculty: Janelle Burnham, MD – Otsuka Pharmaceutical Co Ltd
    Faculty: Michael Pacanowski, PharmD, MPH – US Food & Drug Administration
    Faculty: Justin Hay, PhD – Certara
    Specific Populations/Rare Diseases
     CE: 1.5
  • 5:00 PM - 7:00 PM EDT
    Evening Reception, Exhibits & Poster Session 2
  • 7:00 PM - 9:00 PM EDT
    JCP & CPDD Editorial Board Dinner (Invitation only)
  • Tuesday, September 29, 2026
  • 7:00 AM - 7:45 AM EDT
    STEP & ESP Gathering
  • 7:00 AM - 8:00 AM EDT
    Continental Breakfast
  • 7:00 AM - 3:30 PM EDT
    ACCP Registration Open
  • 8:00 AM - 9:30 AM EDT
    Symposium 10: HOT TOPIC: Maternal-Fetal & Neonatal Pharmacology: Integrating Clinical Insight & Modeling to Advance Drug Therapy in Fetal & Neonatal Care
    Co-Chair: Natalia V. de Moraes, PhD – Univ of Florida Coll of Pharmacy
    Co-Chair & Faculty: Jashvant Unadkat, PhD – Univ of Washington
    Co-Chair & Faculty: John N. van den Anker, MD, PhD – Children’s National Hosp
    Faculty: Christoph P. Hornik, MD, PhD – Duke Univ Medical Ctr
    Specific Populations/Rare Diseases
     CE: 1.5
  • 8:00 AM - 9:30 AM EDT
    Symposium 9: Maximizing Patient Outcomes: Immunogenicity Insights for Drug Development & Therapeutic Care
    Co-Chair & Faculty: Sihem Ait-Oudhia, PhD – Merck & Co Inc
    Co-Chair & Faculty: Bernd Meibohm, PhD – University of Tennessee Health Science Center
    Faculty: Eleni Caratzas, PhD (she/her/hers) – Johnson & Johnson
    Faculty: Michael Swanson, PhD – GlaxoSmithKline plc
    Faculty: Yow-Ming Wang, PhD – US Food & Drug Administration
    Novel Mechanisms & Emerging Therapeutic Modalities
     CE: 1.5
  • 9:30 AM - 10:00 AM EDT
    Coffee & Networking Break
  • 10:00 AM - 11:30 AM EDT
    Symposium 11: Transforming Clinical Pharmacology & Drug Safety: Enhancing Patient Safety Through Advanced Technology, Integrated Surveillance, Postmarket Strategies & Life Cycle Management
    Co-Chair & Faculty: Myong Jin Kim, PharmD
    Co-Chair & Faculty: Kyung-Sang Yu, MD, PhD – Seoul National Univ Hosp
    Faculty: Sara Camilli, PharmD – US Food & Drug Administration
    Faculty: Liang Zhao, PhD – Univ of California, San Francisco
    Artificial Intelligence/Technology Platforms from Drug Discovery to Patient Care
     CE: 1.5
  • 10:00 AM - 11:30 AM EDT
    Symposium 12: HOT TOPIC: Enabling Safe & Informed Therapeutics in Lactation: Role of the Clinical Pharmacologist
    Co-Chair & Faculty: Joga Gobburu, PhD – Univ of Maryland, Baltimore
    Co-Chair & Faculty: Elizabeth Lakota, PharmD, MS (she/her/hers) – Vertex Pharmaceuticals Ltd
    Faculty: Brooke Langevin, BS – Univ of Maryland
    Faculty: Sara Quinney, PharmD, PhD – Indiana Univ
    Specific Populations/Rare Diseases
     CE: 1.5
  • 11:30 AM - 1:30 PM EDT
    Lunch Buffet
  • 11:45 AM - 1:15 PM EDT
    Lunch & Annual Business Meeting (Open to all)
  • 1:30 PM - 3:00 PM EDT
    Symposium 13: Molecules, Models & Modalities from CAR-Ts to siRNAs: Clinical Pharmacology on the Frontier
    Chair & Faculty: Ahmed H. Salem, PhD, FCP – AbbVie Inc
    Faculty: Ahmed Nader, PhD – GlaxoSmithKline plc
    Faculty: Angela Parks – Servier
    Faculty: Ahmed M. Salem, PhD – AstraZeneca plc
    Novel Mechanisms & Emerging Therapeutic Modalities
     CE: 1.5
  • 1:30 PM - 3:00 PM EDT
    Symposium 14: Drug Dosing Equity for All Patients: Utilization of a Companion Drug Label
    Chair & Faculty: Daniel L. Weiner, PhD (he/him/his) – Univ of North Carolina
    Faculty: Jack Cook, PhD (he/him/his) – A2-Ai
    Faculty: Daniel Gonzalez, PharmD, PhD (he/him/his) – Duke Univ
    Faculty: Norman Stockbridge, MD, PhD – S & S Consulting Partners LLC
    Innovative Clinical Pharmacology Strategies for Dose Optimization/Model-Informed Drug Development
     CE: 1.5
  • 3:00 PM - 3:30 PM EDT
    Coffee & Networking Break
  • 3:30 PM - 5:00 PM EDT
    Symposium 15: Rethinking Bridging: Understanding the Role of Modeling & Simulation & Strategic Approaches for Bridging Drug-Device Combinations

    Co-Chair & Faculty: Joga Gobburu, PhD – Univ of Maryland, Baltimore

    Co-Chair & Faculty: Amir S. Youssef, PhD – GlaxoSmithKline plc

    Faculty: Zhe Li, PhD – US Food & Drug Administration

    Faculty: Sandra Suarez-Sharp, PhD – Simulations Plus

  • 3:30 PM - 5:00 PM EDT
    Symposium 15: Rethinking Bridging: Understanding the Role of Modeling & Simulation and Strategic Approaches for Bridging Drug-Device Combinations
    Co-Chair & Faculty: Joga Gobburu, PhD – Univ of Maryland, Baltimore
    Co-Chair & Faculty: Amir S. Youssef, PhD – GlaxoSmithKline plc
    Faculty: Sandra Suarez-Sharp, PhD – Simulations Plus
    Innovative Clinical Pharmacology Strategies for Dose Optimization/Model-Informed Drug Development
     CE: 1.5